Skip to main content

Month: January 2024

RespireRx Pharmaceuticals Inc. Announces the Publication of a Case Report in which KRM-II-81 Totally Suppressed Epileptiform Activity in Brain Tissue Surgically Removed from Epileptic Patient

Glen Rock, N.J., Jan. 04, 2024 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to announce the publication of a case report in Heliyon, Cell Press’s peer-reviewed journal (available at https://www.cell.com/heliyon/pdf/S2405-8440(23)10960-1.pdf) involving a 19-year old patient with pharmaco-resistant epilepsy. As is often the case with such patients, tolerance developed to the standard anti-epileptic treatments, rendering them ineffective, and the patient required a craniotomy in order to remove the brain tissue responsible for the seizure generation. One year after surgery, the patient remains seizure free, but remains...

Continue reading

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer

Figure 1Magnetic resonance imaging (MRI) of the orbital tumor. The top left MRI image shows the tumor in the right orbit behind the eye with the eye not being visible pre-treatment. After treatment with the Bria-IMT™ regimen, the eye becomes visible (top right image) as it has regained its normal position. In the lower images, the dashed line represents normal margin of eye position with resolution of proptosis post treatment (small arrows) with the Bria-IMT™ regimen. Reduction in tumor is represented by large arrows.Significant reduction of metastatic breast cancer tumor behind-the-eye after only 3 cycles Powerful anti-tumor response associated with reduction in proptosis (eye-bulging) and reduced ocular pain Heavily pre-treated patient had failed 7 prior regimens including antibody-drug conjugate therapy and remains...

Continue reading

iCoreConnect Inc. Announces Strategic Acquisition of Teamworx Dental

Acquisition Expands the Company’s Portfolio With Launch of iCoreAcademy Solution OCOEE, FL, Jan. 04, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – iCoreConnect Inc. (NASDAQ: ICCT)(“iCore” or the “Company”), a leading cloud-based software and technology company focused on increasing workflow productivity and customer profitability through its enterprise and healthcare workflow platform, announced today its strategic acquisition of Teamworx Dental (“Teamworx”). This acquisition continues to expand iCoreConnect’s portfolio of SaaS software that serves the healthcare market. Teamworx provides patient education and lead generation software for dental practices with over 100 high-definition, 3D virtual-treatment planning and case acceptance videos that span Oral Surgery, Implants, Pediatrics, and more. Its patient education videos...

Continue reading

Tuttle Capital Management Launches 2x Inverse Regional Bank ETF

SKRE Becomes only ETF that shorts regional banks GREENWICH, Conn., Jan. 04, 2024 (GLOBE NEWSWIRE) — via IBN — The 2x Inverse Regional Bank ETF, (NASDAQ: SKRE), will start trading today at the Nasdaq Exchange. The fund uses swaps to gain inverse daily 2x exposure to the SPDR S&P Regional Banking ETF (Symbol: KRE). Matthew Tuttle, CEO of Tuttle Capital, said in a news release that SKRE is a trading tool that has long been needed in the marketplace. “This year saw a number of regional banks go under” Tuttle said. “These guys are not too big to fail, when they start to have problems, things can spiral quickly, and nobody is going to bail them out.” Tuttle is concerned that the higher for longer interest rate stance by the Fed and potential issues in commercial real estate could mean that we see more regional banks go under...

Continue reading

Rocky Mountain Chocolate Schedules Fiscal Third Quarter 2024 Conference Call for January 11, 2024 at 8:30 A.M. ET

DURANGO, Colo., Jan. 04, 2024 (GLOBE NEWSWIRE) — Rocky Mountain Chocolate Factory Inc. (Nasdaq: RMCF) (the “Company”, “we”, “RMC”, or “Rocky Mountain Chocolate”), an international franchisor and producer of premium chocolates and other confectionery products, including gourmet caramel apples, will host a conference call on Thursday, January 11, 2024 at 8:30 a.m. Eastern time to discuss its fiscal third quarter 2024 results. The Company’s results will be reported in a press release prior to the call. The RMCF management team will host the conference call, followed by a question-and-answer period. Attendees are invited to submit questions ahead of the call by emailing the Company’s investor relations team at RMCF@elevate-ir.com. The conference call details are as follows: Date: Thursday, January 11, 2024Time: 8:30 a.m. Eastern timeDial-in...

Continue reading

C-Bond Systems Reviews 2023 Highlights Including Record Revenue

Highlights include record revenue so far this year, asset sale of $4 million, strengthened balance sheet, elimination of convertible debt, and a strong pipeline for 2024 SAN ANTONIO, Jan. 04, 2024 (GLOBE NEWSWIRE) — C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a developer and marketer of glass strengthening solutions for enhanced safety, announced today its 2023 highlights. The Company also participated in an investor podcast to discuss 2023 achievements and 2024 goals, which can be heard here: https://www.youtube.com/watch?v=64_UULOJ3zM 2023 HighlightsRevenue was over $1.7 million for the first nine months of 2023, exceeding revenue for the first nine-month period of any prior year, even without the contribution of any revenue from our previously owned C-Bond nanoShield product, which we sold in the second quarter...

Continue reading

Signing Day Sports CEO Provides Letter to Stockholders

Signing Day Sports Recruitment AppSigning Day Sports Recruitment App Highly scalable business model, well suited for rapid adaptation across various sports Direct digital marketing expected to drive growth and engagement Collaboration with U.S. Army Bowl showcases the app’s athlete recruitment capabilitiesSigning Day Sports Recruitment AppSCOTTSDALE, Ariz, Jan. 04, 2024 (GLOBE NEWSWIRE) — Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), the developer of the Signing Day Sports app and platform to aid high school athletes in the recruitment process, today provided the following letter to stockholders from the Company’s Chairman and CEO, Daniel Nelson: Dear Stockholders, We are pleased to share with you a recap of the significant milestones and exciting developments that...

Continue reading

Kineta to Participate in the 13th Annual LifeSci Partners Corporate Access Event

SEATTLE, Jan. 04, 2024 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that management will participate in the 13th Annual LifeSci Partners Corporate Access Event, taking place January 8-10, 2024 at the Beacon Grand Hotel in San Francisco, California during J.P. Morgan week. “We look forward to participating in the LifeSci Corporate Access Event and to hosting in-person meetings with investors, strategic partners, analysts and other stakeholders”, said Shawn Iadonato, Ph.D., Chief Executive Officer of Kineta. “2024 has the potential to be a substantial growth year as we continue to make significant progress on the clinical development of KVA12123, our novel VISTA immunotherapy.” During...

Continue reading

Golden Grail Beverages Ends 2023 with Milestone Accomplishments: Laying a Foundation for Shareholder Value in 2024

FORT LAUDERDALE, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) — Golden Grail Beverages (OTC: GOGY), a beverage company dedicated to pioneering and nurturing sustainable brands, celebrates a year of exceptional achievements in 2023, laying a solid foundation for shareholder value in 2024. The company’s strategic rebranding, new product launches, and key partnerships have significantly contributed to its growth and success. Golden Grail Beverages: A Future Filled with Potential in 2024 Golden Grail Beverages enters 2024 with unwavering momentum and a vision for continued growth. The company remains committed to innovating within emerging beverage categories, prioritizing sustainability, and delivering quality and value to consumers. This dedication to transformation, partnership, and responsible growth promises an exciting future...

Continue reading

Roper Technologies schedules fourth quarter 2023 financial results conference call

SARASOTA. Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) — Roper Technologies, Inc. (Nasdaq: ROP) announced that its financial results for the fourth quarter of 2023, ended December 31, 2023, will be released before the market opens on Wednesday, January 31, 2024. A conference call to discuss these results has been scheduled for 8:00 AM ET on Wednesday, January 31, 2024. The call can be accessed via webcast or by dialing +1 844-750-4898 (US/Canada) or +1 412-317-5294, using confirmation number 10185260. Webcast information and conference call materials will be made available in the Investors section of Roper’s website prior to the start of the call. About Roper Technologies Roper Technologies is a constituent of the Nasdaq 100, S&P 500, and Fortune 1000. Roper has a proven, long-term track record of compounding cash flow and shareholder...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.